2.16.840.1.113883.5.145/static-2012-07-24: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
(Automated TermBot page content)
 
(Automated TermBot page content)
Zeile 9: Zeile 9:
 
| colspan=2 bgcolor="#F6F3EE"|''VaccineType''
 
| colspan=2 bgcolor="#F6F3EE"|''VaccineType''
 
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.145
 
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.145
| bgcolor="#F6F3EE"|2012-07-24
+
| bgcolor="#F6F3EE"|2012-07-24T00:00:00
 
| bgcolor="#F6F3EE"|definitiv
 
| bgcolor="#F6F3EE"|definitiv
 
|-
 
|-
Zeile 17: Zeile 17:
 
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
 
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
 
|-
 
|-
|-
 
|0-L
 
|'''54'''
 
|<font color="grey">(en-US)</font> adenovirus, type 4
 
| colspan="2" |<p>adenovirus vaccine, type 4, live, oral</p>
 
|-
 
|0-L
 
|'''55'''
 
|<font color="grey">(en-US)</font> adenovirus, type 7
 
| colspan="2" |<p>adenovirus vaccine, type 7, live, oral</p>
 
|-
 
|0-L
 
|'''82'''
 
|<font color="grey">(en-US)</font> adenovirus, NOS
 
| colspan="2" |<p>adenovirus vaccine, NOS</p>
 
|-
 
|0-L
 
|'''24'''
 
|<font color="grey">(en-US)</font> Anthrax
 
| colspan="2" |<p>anthrax vaccine</p>
 
|-
 
|0-L
 
|'''19'''
 
|<font color="grey">(en-US)</font> BCG
 
| colspan="2" |<p>Bacillus Calmette-Guerin vaccine</p>
 
|-
 
|0-L
 
|'''27'''
 
|<font color="grey">(en-US)</font> botulinum antitoxin
 
| colspan="2" |<p>botulinum antitoxin</p>
 
|-
 
|0-L
 
|'''26'''
 
|<font color="grey">(en-US)</font> Cholera
 
| colspan="2" |<p>cholera vaccine</p>
 
|-
 
|0-L
 
|'''29'''
 
|<font color="grey">(en-US)</font> CMVIG
 
| colspan="2" |<p>cytomegalovirus immune globulin, intravenous</p>
 
|-
 
|0-L
 
|'''56'''
 
|<font color="grey">(en-US)</font> dengue fever
 
| colspan="2" |<p>dengue fever vaccine</p>
 
|-
 
|0-L
 
|'''12'''
 
|<font color="grey">(en-US)</font> diphtheria antitoxin
 
| colspan="2" |<p>diphtheria antitoxin</p>
 
|-
 
|0-L
 
|'''28'''
 
|<font color="grey">(en-US)</font> DT (pediatric)
 
| colspan="2" |<p>diphtheria and tetanus toxoids, adsorbed for pediatric use</p>
 
|-
 
|0-L
 
|'''20'''
 
|<font color="grey">(en-US)</font> DTaP
 
| colspan="2" |<p>diphtheria, tetanus toxoids and acellular pertussis vaccine</p>
 
|-
 
|0-L
 
|'''50'''
 
|<font color="grey">(en-US)</font> DTaPHib
 
| colspan="2" |<p>DTaP-Haemophilus influenzae type b conjugate vaccine</p>
 
|-
 
|0-L
 
|'''1'''
 
|<font color="grey">(en-US)</font> DTP
 
| colspan="2" |<p>diphtheria, tetanus toxoids and pertussis vaccine</p>
 
|-
 
|0-L
 
|'''22'''
 
|<font color="grey">(en-US)</font> DTP-Hib
 
| colspan="2" |<p>DTP-Haemophilus influenzae type b conjugate vaccine</p>
 
|-
 
|0-L
 
|'''57'''
 
|<font color="grey">(en-US)</font> Hantavirus
 
| colspan="2" |<p>hantavirus vaccine</p>
 
|-
 
|0-L
 
|'''52'''
 
|<font color="grey">(en-US)</font> Hep A, adult
 
| colspan="2" |<p>hepatitis A vaccine, adult dosage</p>
 
|-
 
|0-L
 
|'''83'''
 
|<font color="grey">(en-US)</font> Hep A, ped/adol, 2 dose
 
| colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</p>
 
|-
 
|0-L
 
|'''84'''
 
|<font color="grey">(en-US)</font> Hep A, ped/adol, 3 dose
 
| colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</p>
 
|-
 
|0-L
 
|'''31'''
 
|<font color="grey">(en-US)</font> Hep A, pediatric, NOS
 
| colspan="2" |<p>hepatitis A vaccine, pediatric dosage, NOS</p>
 
|-
 
|0-L
 
|'''85'''
 
|<font color="grey">(en-US)</font> Hep A, NOS
 
| colspan="2" |<p>hepatitis A vaccine, NOS</p>
 
|-
 
|0-L
 
|'''30'''
 
|<font color="grey">(en-US)</font> HBIG
 
| colspan="2" |<p>hepatitis B immune globulin</p>
 
|-
 
|0-L
 
|'''8'''
 
|<font color="grey">(en-US)</font> Hep B, adolescent or pediatric
 
| colspan="2" |<p>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</p>
 
|-
 
|0-L
 
|'''42'''
 
|<font color="grey">(en-US)</font> Hep B, adolescent/high risk infant
 
| colspan="2" |<p>hepatitis B vaccine, adolescent/high risk infant dosage</p>
 
|-
 
|0-L
 
|'''43'''
 
|<font color="grey">(en-US)</font> Hep B, adult
 
| colspan="2" |<p>hepatitis B vaccine, adult dosage</p>
 
|-
 
|0-L
 
|'''44'''
 
|<font color="grey">(en-US)</font> Hep B, dialysis
 
| colspan="2" |<p>hepatitis B vaccine, dialysis patient dosage</p>
 
|-
 
|0-L
 
|'''45'''
 
|<font color="grey">(en-US)</font> Hep B, NOS
 
| colspan="2" |<p>hepatitis B vaccine, NOS</p>
 
|-
 
|0-L
 
|'''58'''
 
|<font color="grey">(en-US)</font> Hep C
 
| colspan="2" |<p>hepatitis C vaccine</p>
 
|-
 
|0-L
 
|'''59'''
 
|<font color="grey">(en-US)</font> Hep E
 
| colspan="2" |<p>hepatitis E vaccine</p>
 
|-
 
|0-L
 
|'''60'''
 
|<font color="grey">(en-US)</font> herpes simplex 2
 
| colspan="2" |<p>herpes simplex virus, type 2 vaccine</p>
 
|-
 
|0-L
 
|'''46'''
 
|<font color="grey">(en-US)</font> Hib (PRP-D)
 
| colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-D conjugate</p>
 
|-
 
|0-L
 
|'''47'''
 
|<font color="grey">(en-US)</font> Hib (HbOC)
 
| colspan="2" |<p>Haemophilus influenzae type b vaccine, HbOC conjugate</p>
 
|-
 
|0-L
 
|'''48'''
 
|<font color="grey">(en-US)</font> Hib (PRP-T)
 
| colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-T conjugate</p>
 
|-
 
|0-L
 
|'''49'''
 
|<font color="grey">(en-US)</font> Hib (PRP-OMP)
 
| colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</p>
 
|-
 
|0-L
 
|'''17'''
 
|<font color="grey">(en-US)</font> Hib, NOS
 
| colspan="2" |<p>Haemophilus influenzae type b vaccine, conjugate NOS</p>
 
|-
 
|0-L
 
|'''51'''
 
|<font color="grey">(en-US)</font> Hib-Hep B
 
| colspan="2" |<p>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</p>
 
|-
 
|0-L
 
|'''61'''
 
|<font color="grey">(en-US)</font> HIV
 
| colspan="2" |<p>human immunodeficiency virus vaccine</p>
 
|-
 
|0-L
 
|'''62'''
 
|<font color="grey">(en-US)</font> HPV
 
| colspan="2" |<p>human papilloma virus vaccine</p>
 
|-
 
|0-L
 
|'''86'''
 
|<font color="grey">(en-US)</font> IG
 
| colspan="2" |<p>immune globulin, intramuscular</p>
 
|-
 
|0-L
 
|'''87'''
 
|<font color="grey">(en-US)</font> IGIV
 
| colspan="2" |<p>immune globulin, intravenous</p>
 
|-
 
|0-L
 
|'''14'''
 
|<font color="grey">(en-US)</font> IG, NOS
 
| colspan="2" |<p>immune globulin, NOS</p>
 
|-
 
|0-L
 
|'''15'''
 
|<font color="grey">(en-US)</font> influenza, split (incl. purified surface antigen)
 
| colspan="2" |<p>influenza virus vaccine, split virus (incl. purified surface antigen)</p>
 
|-
 
|0-L
 
|'''16'''
 
|<font color="grey">(en-US)</font> influenza, whole
 
| colspan="2" |<p>influenza virus vaccine, whole virus</p>
 
|-
 
|0-L
 
|'''88'''
 
|<font color="grey">(en-US)</font> influenza, NOS
 
| colspan="2" |<p>influenza virus vaccine, NOS</p>
 
|-
 
|0-L
 
|'''10'''
 
|<font color="grey">(en-US)</font> IPV
 
| colspan="2" |<p>poliovirus vaccine, inactivated</p>
 
|-
 
|0-L
 
|'''2'''
 
|<font color="grey">(en-US)</font> OPV
 
| colspan="2" |<p>poliovirus vaccine, live, oral</p>
 
|-
 
|0-L
 
|'''89'''
 
|<font color="grey">(en-US)</font> polio, NOS
 
| colspan="2" |<p>poliovirus vaccine, NOS</p>
 
|-
 
|0-L
 
|'''39'''
 
|<font color="grey">(en-US)</font> Japanese encephalitis
 
| colspan="2" |<p>Japanese encephalitis vaccine</p>
 
|-
 
|0-L
 
|'''63'''
 
|<font color="grey">(en-US)</font> Junin virus
 
| colspan="2" |<p>Junin virus vaccine</p>
 
|-
 
|0-L
 
|'''64'''
 
|<font color="grey">(en-US)</font> leishmaniasis
 
| colspan="2" |<p>leishmaniasis vaccine</p>
 
|-
 
|0-L
 
|'''65'''
 
|<font color="grey">(en-US)</font> leprosy
 
| colspan="2" |<p>leprosy vaccine</p>
 
|-
 
|0-L
 
|'''66'''
 
|<font color="grey">(en-US)</font> Lyme disease
 
| colspan="2" |<p>Lyme disease vaccine</p>
 
|-
 
|0-L
 
|'''3'''
 
|<font color="grey">(en-US)</font> MMR
 
| colspan="2" |<p>measles, mumps and rubella virus vaccine</p>
 
|-
 
|0-L
 
|'''4'''
 
|<font color="grey">(en-US)</font> M/R
 
| colspan="2" |<p>measles and rubella virus vaccine</p>
 
|-
 
|0-L
 
|'''94'''
 
|<font color="grey">(en-US)</font> MMRV
 
| colspan="2" |<p>measles, mumps, rubella, and varicella virus vaccine</p>
 
|-
 
|0-L
 
|'''67'''
 
|<font color="grey">(en-US)</font> malaria
 
| colspan="2" |<p>malaria vaccine</p>
 
|-
 
|0-L
 
|'''5'''
 
|<font color="grey">(en-US)</font> measles
 
| colspan="2" |<p>measles virus vaccine</p>
 
|-
 
|0-L
 
|'''68'''
 
|<font color="grey">(en-US)</font> melanoma
 
| colspan="2" |<p>melanoma vaccine</p>
 
|-
 
|0-L
 
|'''32'''
 
|<font color="grey">(en-US)</font> meningococcal
 
| colspan="2" |<p>meningococcal polysaccharide vaccine</p>
 
|-
 
|0-L
 
|'''7'''
 
|<font color="grey">(en-US)</font> mumps
 
| colspan="2" |<p>mumps virus vaccine</p>
 
|-
 
|0-L
 
|'''69'''
 
|<font color="grey">(en-US)</font> parainfluenza-3
 
| colspan="2" |<p>parainfluenza-3 virus vaccine</p>
 
|-
 
|0-L
 
|'''11'''
 
|<font color="grey">(en-US)</font> pertussis
 
| colspan="2" |<p>pertussis vaccine</p>
 
|-
 
|0-L
 
|'''23'''
 
|<font color="grey">(en-US)</font> plague
 
| colspan="2" |<p>plague vaccine</p>
 
|-
 
|0-L
 
|'''33'''
 
|<font color="grey">(en-US)</font> pneumococcal
 
| colspan="2" |<p>pneumococcal polysaccharide vaccine</p>
 
|-
 
|0-L
 
|'''100'''
 
|<font color="grey">(en-US)</font> pneumococcal conjugate
 
| colspan="2" |<p>pneumococcal conjugate vaccine, polyvalent</p>
 
|-
 
|0-L
 
|'''70'''
 
|<font color="grey">(en-US)</font> Q fever
 
| colspan="2" |<p>Q fever vaccine</p>
 
|-
 
|0-L
 
|'''18'''
 
|<font color="grey">(en-US)</font> rabies, intramuscular injection
 
| colspan="2" |<p>rabies vaccine, for intramuscular injection</p>
 
|-
 
|0-L
 
|'''40'''
 
|<font color="grey">(en-US)</font> rabies, intradermal injection
 
| colspan="2" |<p>rabies vaccine, for intradermal injection</p>
 
|-
 
|0-L
 
|'''90'''
 
|<font color="grey">(en-US)</font> rabies, NOS
 
| colspan="2" |<p>rabies vaccine, NOS</p>
 
|-
 
|0-L
 
|'''72'''
 
|<font color="grey">(en-US)</font> rheumatic fever
 
| colspan="2" |<p>rheumatic fever vaccine</p>
 
|-
 
|0-L
 
|'''73'''
 
|<font color="grey">(en-US)</font> Rift Valley fever
 
| colspan="2" |<p>Rift Valley fever vaccine</p>
 
|-
 
|0-L
 
|'''34'''
 
|<font color="grey">(en-US)</font> RIG
 
| colspan="2" |<p>rabies immune globulin</p>
 
|-
 
|0-L
 
|'''74'''
 
|<font color="grey">(en-US)</font> rotavirus
 
| colspan="2" |<p>rotavirus vaccine, tetravalent, live, oral</p>
 
|-
 
|0-L
 
|'''71'''
 
|<font color="grey">(en-US)</font> RSV-IGIV
 
| colspan="2" |<p>respiratory syncytial virus immune globulin, intravenous</p>
 
|-
 
|0-L
 
|'''93'''
 
|<font color="grey">(en-US)</font> RSV-Mab
 
| colspan="2" |<p>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</p>
 
|-
 
|0-L
 
|'''6'''
 
|<font color="grey">(en-US)</font> rubella
 
| colspan="2" |<p>rubella virus vaccine</p>
 
|-
 
|0-L
 
|'''38'''
 
|<font color="grey">(en-US)</font> rubella/mumps
 
| colspan="2" |<p>rubella and mumps virus vaccine</p>
 
|-
 
|0-L
 
|'''75'''
 
|<font color="grey">(en-US)</font> smallpox
 
| colspan="2" |<p>smallpox vaccine</p>
 
|-
 
|0-L
 
|'''76'''
 
|<font color="grey">(en-US)</font> Staphylococcus bacterio lysate
 
| colspan="2" |<p>Staphylococcus bacteriophage lysate</p>
 
|-
 
|0-L
 
|'''9'''
 
|<font color="grey">(en-US)</font> Td (adult)
 
| colspan="2" |<p>tetanus and diphtheria toxoids, adsorbed for adult use</p>
 
|-
 
|0-L
 
|'''35'''
 
|<font color="grey">(en-US)</font> tetanus toxoid
 
| colspan="2" |<p>tetanus toxoid</p>
 
|-
 
|0-L
 
|'''77'''
 
|<font color="grey">(en-US)</font> tick-borne encephalitis
 
| colspan="2" |<p>tick-borne encephalitis vaccine</p>
 
|-
 
|0-L
 
|'''13'''
 
|<font color="grey">(en-US)</font> TIG
 
| colspan="2" |<p>tetanus immune globulin</p>
 
|-
 
|0-L
 
|'''95'''
 
|<font color="grey">(en-US)</font> TST-OT tine test
 
| colspan="2" |<p>tuberculin skin test; old tuberculin, multipuncture device</p>
 
|-
 
|0-L
 
|'''96'''
 
|<font color="grey">(en-US)</font> TST-PPD intradermal
 
| colspan="2" |<p>tuberculin skin test; purified protein derivative solution, intradermal</p>
 
|-
 
|0-L
 
|'''97'''
 
|<font color="grey">(en-US)</font> TST-PPD tine test
 
| colspan="2" |<p>tuberculin skin test; purified protein derivative, multipuncture device</p>
 
|-
 
|0-L
 
|'''98'''
 
|<font color="grey">(en-US)</font> TST, NOS
 
| colspan="2" |<p>tuberculin skin test; NOS</p>
 
|-
 
|0-L
 
|'''78'''
 
|<font color="grey">(en-US)</font> tularemia vaccine
 
| colspan="2" |<p>tularemia vaccine</p>
 
|-
 
|0-L
 
|'''25'''
 
|<font color="grey">(en-US)</font> typhoid, oral
 
| colspan="2" |<p>typhoid vaccine, live, oral</p>
 
|-
 
|0-L
 
|'''41'''
 
|<font color="grey">(en-US)</font> typhoid, parenteral
 
| colspan="2" |<p>typhoid vaccine, parenteral, other than acetone-killed, dried</p>
 
|-
 
|0-L
 
|'''53'''
 
|<font color="grey">(en-US)</font> typhoid, parenteral, AKD (U.S. military)
 
| colspan="2" |<p>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</p>
 
|-
 
|0-L
 
|'''101'''
 
|<font color="grey">(en-US)</font> typhoid, ViCPs
 
| colspan="2" |<p>Typhoid Vi capsular polysaccharide vaccine</p>
 
|-
 
|0-L
 
|'''91'''
 
|<font color="grey">(en-US)</font> typhoid, NOS
 
| colspan="2" |<p>typhoid vaccine, NOS</p>
 
|-
 
|0-L
 
|'''79'''
 
|<font color="grey">(en-US)</font> vaccinia immune globulin
 
| colspan="2" |<p>vaccinia immune globulin</p>
 
|-
 
|0-L
 
|'''21'''
 
|<font color="grey">(en-US)</font> varicella
 
| colspan="2" |<p>varicella virus vaccine</p>
 
|-
 
|0-L
 
|'''81'''
 
|<font color="grey">(en-US)</font> VEE, inactivated
 
| colspan="2" |<p>Venezuelan equine encephalitis, inactivated</p>
 
|-
 
|0-L
 
|'''80'''
 
|<font color="grey">(en-US)</font> VEE, live
 
| colspan="2" |<p>Venezuelan equine encephalitis, live, attenuated</p>
 
|-
 
|0-L
 
|'''92'''
 
|<font color="grey">(en-US)</font> VEE, NOS
 
| colspan="2" |<p>Venezuelan equine encephalitis vaccine, NOS</p>
 
|-
 
|0-L
 
|'''36'''
 
|<font color="grey">(en-US)</font> VZIG
 
| colspan="2" |<p>varicella zoster immune globulin</p>
 
|-
 
|0-L
 
|'''37'''
 
|<font color="grey">(en-US)</font> yellow fever
 
| colspan="2" |<p>yellow fever vaccine</p>
 
 
|}
 
|}

Version vom 11. November 2012, 13:14 Uhr

Codesystem Name Codesystem Id Version / Eingangsdatum Status
VaccineType 2.16.840.1.113883.5.145 2012-07-24T00:00:00 definitiv
Level/Typ Code Anzeigename Beschreibung